Chronic Obstructive Pulmonary Disease in America's Black Population
Chronic Obstructive Pulmonary Disease in America's Black Population
复制标题
DOI:
10.1164/rccm.201810-1909pp
复制
发表时间:
2019-08-15
影响因子:
24.7
通讯作者:
Han, MeiLan K.
中科院分区:
文献类型:
--
作者:
Ejike, Chinedu O.;Dransfield, Mark T.;Han, MeiLan K.
Chronic obstructive pulmonary disease (COPD) is a progressive, debilitating respiratory condition and currently the third leading cause of death in the United States (1). Though over 11 million people have been diagnosed with COPD, many more have undiagnosed disease (1). This number is projected to increase further as America’s population ages. COPD is increasingly being recognized as a major health problem in America’s multicultural black population. Until recent studies such as COPDGene (Genetic Study of the Epidemiology of COPD)(2), which recruited a significant number of black individuals, there have not been many COPD studies inclusive enough of the black population in America to understand how the disease affects or may differ in the black population. Furthermore, evidence indicates that the prevalence and morbidity of COPD vary widely among US-born black individuals versus black immigrants. This brings into question the validity of current knowledge, which largely refers to all “US blacks” as a homogeneous “African American” populace in a majority of studies. This assumption ignores the variations in socioeconomic status, tobacco or biomass smoke exposure, behaviors, access to health care, health insurance coverage, and disease management among black individuals in America. In this pulmonary perspective article, we define America’s black population and examine the prevalence, risk factors, morbidity, and mortality attributed to COPD among black individuals in